Publication | Open Access
In Vivo Evaluation of a Cancer Therapy Strategy Combining HSV1716-Mediated Oncolysis with Gene Transfer and Targeted Radiotherapy
19
Citations
31
References
2012
Year
These findings support a role for combination radiotherapy-gene therapy for cancer using HSV1716 expressing the NAT transgene and targeted radionuclide therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1